In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 90, Issue 2, 2010, Pages 99-102

  Tyl, Rochelle W ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

Developmental toxicity and testing; Teratology Society

Indexed keywords

BENDECTIN; ENDOCRINE DISRUPTOR; FUNGICIDE; PESTICIDE; RODENTICIDE; THALIDOMIDE; TOXIC SUBSTANCE;

BODY WEIGHT; CORPUS LUTEUM; DESCRIPTIVE RESEARCH; DRUG MARKETING; DRUG SCREENING; EPIGENETICS; FETUS MALFORMATION; FETUS WEIGHT; FLUID INTAKE; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; GESTATIONAL AGE; GOVERNMENT; IN VITRO STUDY; IN VIVO STUDY; JAPAN; NONHUMAN; ORGANOGENESIS; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PHOCOMELIA; PRACTICE GUIDELINE; PREDICTION; PREGNANCY TERMINATION; PREIMPLANTATION EMBRYO; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RABBIT; REPRODUCTIVE TOXICITY; REVIEW; RODENT; SEX RATIO; SOCIETY; SURVIVAL; TERATOGENICITY; TERATOLOGY; TOXICOLOGY; UNITED KINGDOM; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; ANNIVERSARIES AND SPECIAL EVENTS; FEMALE; GUIDELINES AS TOPIC; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MALE; MICE; RABBITS; RATS; SOCIETIES, SCIENTIFIC; TERATOLOGY; TOXICITY TESTS;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 77953481381     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20176     Document Type: Review

References (26)

1. Brent RL. 1983. The bendectin saga. Another American tragedy. Teratology 27:283-286.
2. Brent RL. 1985. Editorial: bendectin and interventricular septal defects. Teratology 32:317-318.
3. Brent RL. 1988. Bendectin: our most famous tortogen-litigen and the best studied human non-teratogen. The absence of a clinical bendectin syndrome. Teratology 37.
4. Brent RL. 1995. Commentary: bringing scholarship to the courtroom: the Daubert decision and its impact on the Teratology Society. Teratology 52:247-251.
5. Canada. 1973. Canada Ministry of Health and Welfare, Health Protection Branch. The testing of chemicals for carcinogenicity, mutagenicity and teratogenicity. The Ministry of Ottawa.
6. Cooper RL, Lamb JC, Barlow SM, et al. 2006. A tiered approach to life stages testing for agricultural safety assessment. Critical Rev Toxicol 36:69-98.
7. Cooper RL. 2009. Current development in reproductive toxicity testing of pesticides. Reprod Toxicol 28:180-187.
8. Dayton L. 1993. Thalidomide hero found guilty of scientific fraud. New Scientist, 27 February 1993.
9. FDA. 1994. Food and Drug Administration. International Conference on Harmonisation (ICH); guideline for detection of toxicity to reproduction for medicinal products. Section 4.1.3, study for effects on embryo-fetal development. Federal Register 59:48749.
10. Goldenthal EI. 1966. Chief, Drug Review Branch, Division of Toxicological Evaluation, Bureau of Scientific Standards and Evaluation: guidelines for reproduction studies for safety evaluation of drugs for human use. EPA, 1996: Federal Register 61:56274-56322
11. Hendrickx AG, Cakierski M, Prahalada S, et al. 1985a. Evaluation of bendectin embryotoxicity in nonhuman primates: 1. Ventricular septal defects in prenatal macaques and baboon. Teratology 32:179-189.
12. Hendrickx AG, Cakierski M, Prahalada S, et al. 1985b. Bendectin embryotoxicity in term cynomolgus monkeys. Teratology 32:191-194.
13. Holmes LB. 1983. Teratogen update: bendectin. Teratology 27:277-281.
14. Japan. 1984. Japanese guidelines of toxicity studies, notification no. 118 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare. 2. Studies of the effects of drugs on reproduction. Tokyo, Japan: Yakagyo Jiho Co., Ltd.
15. Lenz W. 1962. Letter to the Editor. Thalidomide and congenital abnormalities. Lancet 1:45.
16. McBride W. 1961. Letter to the Editor. Thalidomide and congenital abnormalities. Lancet 2:1358.
17. OECD. 1981. Organization for Economic Cooperation and Development. Guideline for testing of chemicals: teratogenicity. Paris, France: Director of Information.
18. OECD. 2007.Organization for Economic Cooperation and Development. OECD guideline for the testing of chemicals. Uterotrophic bioassay in rodents: a short-term screening test for oestrogenic properties. OECD 440.
19. OECD. 2009.Organization for Economic Cooperation and Development. OECD guideline for the testing of chemicals. Hershberger bioassay in rats: a short-term screening assay for (anti)androgenic properties. OECD 441.
20. Rajkumar SV. 2004. Thalidomide: tragic past and promising future. May Clinic Proc 79:899-903.
21. United Kingdom. 1974.Committee on Safety of Medicines: notes for guidance on reproduction studies. Great Britain: Department of Health and Social Security.
22. U.S. EPA. 1984.Pesticides assessment guidelines (FIFRA), subdivision F. Hazard evaluation: human and domestic animals, Section 83-3 (final rule). Springfield, VA: NTIS (PB86-108958).
23. U.S. EPA. 1987. Toxic Substances Control Act (TSCA) test guidelines: final rule. Federal Register 50:39412.
24. U.S. EPA. 1988. Pesticide assessment guidelines, subdivision F hazard evaluation: humans and domestic animals, series 83-3, rat or rabbit developmental toxicity study, June, 1986 (NTIS PB86-248184), as amended in Federal Register 53(86), Section 158.340, May 4, 1988.
25. U.S. EPA. 1996.Office of Prevention, Pesticides and Toxic Substances (OPPTS), Health Effects Test Guidelines, OPPTS 870.3800, reproduction and fertility effects.
26. U.S. EPA. 1998.Office of Prevention, Pesticides and Toxic Substances (OPPTS). Health Effects Test Guidelines OPPTS 870.3700, prenatal developmental toxicity study; final guideline, August 1998.